Differential expression of type I and type II cyclic AMP-dependent protein kinases during cell cycle and cyclic AMP-induced growth arrest.
- 1 June 1980
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 77 (6) , 3445-3449
- https://doi.org/10.1073/pnas.77.6.3445
Abstract
The activation state of cyclic AMP-dependent protein kinase(s)(ATP:protein phosphotransferase, EC 2.7.1.37) is transiently increased 2-fold as a function of G1 progression in mitotically synchronized Chinese hamster ovary cells. The cellular content of type I kinase increases concomitantly with the increase in general protein, whereas the activity of type II kinase increases as a function of time in G1 to a maximum at the G1/S border. In contrast, in the presence of dibutyryl-cyclic AMP, there is a decrease of type II kinase and a several-fold increase of type I kinase. In proliferating cells, the ratio of type I to type II was 0.37, while in the dibutyryl-cyclic AMP growth-arrested cells it was 3.96. The increase in type II kinase during G1 transition and the increase in type I kinase during dibutyryl-cyclic AMP treatment were dependent on protein synthesis. A similar pattern of type I and type II kinase expression during cell cycle progression occurred in Rat-1 fibroblasts and Rat-1 cells transformed by Rous sarcoma virus. The inclusion of dibuityryl-cyclic AMP in the growth media promoted a marked increase in type I holoenzyme, which was inhibited by cycloheximide, and a decrease in type II kinase. Neither AMP nor sodium butyrate had any effect on cellular kinase levels, whereas 8-bromo-cyclic AMP mimicked the action of dibutyryl-cyclic AMP. Estimation of half-lives for the kinase types showed that there was little turnover of either type during normal G1 progression, rapid turnover of both types as cells exited from mitosis, and selective turnover of type II upon addition of dibutyryl-cyclic AMP.This publication has 32 references indexed in Scilit:
- Differential effects of cAMP and cGMP on in vitro epidermal cell growthExperimental Cell Research, 1979
- Increase of cyclic AMP-dependent protein kinase type II as an early event in hormone-dependent mammary tumor regressionBiochemical and Biophysical Research Communications, 1978
- Rise and Fall of Cyclic AMP Required for Onset of Lymphocyte DNA SynthesisScience, 1978
- CHANGES IN ORNITHINE DECARBOXYLASE ACTIVITY AND CYCLIC ADENOSINE‐3′‐5′‐MONOPHOSPHATE CONCENTRATIONS DURING THE CELL CYCLE OF SYNCHRONIZED BHK CELLSImmunology & Cell Biology, 1977
- Type I and type II cyclic AMP-dependent protein kinase as opposite effectors of lymphocyte mitogenesisNature, 1977
- Cyclic AMP, cyclic AMP-dependent protein kinase, and the regulation of gene expressionLife Sciences, 1977
- Increase in type I adenosine 3′,5′-monophosphate-dependent protein kinase during isoproterenol-induced cardiac hypertrophyBiochemical and Biophysical Research Communications, 1976
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Increases in rat liver cyclic AMP concentrations prior to the initiation of DNA synthesis following partial hepatectomy or hormone infusionBiochemical and Biophysical Research Communications, 1972
- Stimulation of DNA synthesis and mitotic activity of thymic lymphocytes by cyclic adenosine 3′5′-monophosphateExperimental Cell Research, 1969